Brianne Wagenman
Medical · El Paso, TXNPI 1598164766
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.2%), consulting fees and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Incyte Corporation at 42.5% of the total. Reporting peaked in 2023 at $1,271 and has fallen 62.0% since, to $482 in 2025.
Across 50 payments — averaging $55.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$1K
- AbbVie$287
- E.r. Squibb & Sons, L.L.C.$191
- Lilly USA, LLC$172
- UCB, Inc.$158
- Dermavant Sciences, Inc.$125
- plus $669 from 15 others
What the payments were for
- Consulting fees$1,02037%
- Food & beverage$1,56456%
- Education$2007%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $1,183 |
| AbbVie | 9 | $287 |
| E.r. Squibb & Sons, L.L.C. | 3 | $191 |
| Lilly USA, LLC | 2 | $172 |
| UCB, Inc. | 6 | $158 |
| Dermavant Sciences, Inc. | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 1 | $97 |
| Journey Medical Corporation | 1 | $88 |
| Pfizer | 4 | $77 |
| Novartis | 3 | $61 |
| Krystal Biotech Inc | 2 | $39 |
| Organon | 4 | $35 |
| AstraZeneca | 1 | $29 |
| LEO Pharma Inc. | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Almirall LLC | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,784 in reported general payments places this provider in the 70th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 20 | $750 |
| Ketoconazole | 15 | $269 |
Paid to pharmacies, not to this prescriber.
Other medical in El Paso
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.